Antihypertensive Drugs

Correct Answer

D — Thiazide-like diuretic

Rationale

Chlorthalidone is a thiazide-like diuretic. Furosemide is a loop diuretic. Spironolactone is an aldosterone antagonist. Acetazolamide is a carbonic anhydrase inhibitor.

Correct Answer

A — Mineralocorticoid receptor antagonists

Rationale

Spironolactone is a mineralocorticoid receptor antagonist. Clonidine is a centrally acting alpha-2 adrenergic receptor agonist. Hydralazine is a direct arteriolar vasodilator. Verapamil is a non-dihydropyridine calcium channel blocker.

Correct Answer

C — Angiotensin receptor-neprilysin inhibitor

Rationale

Sacubitril-valsartan is classified as an angiotensin receptor-neprilysin inhibitor, a fixed-dose combination distinct from the angiotensin converting enzyme inhibitor and mineralocorticoid receptor antagonist classes. Lisinopril is an angiotensin converting enzyme inhibitor. Aliskiren is a direct renin inhibitor. Spironolactone is a mineralocorticoid receptor antagonist.

Correct Answer

B — Nonselective beta-adrenergic receptor antagonist with alpha-1 blockade

Rationale

Carvedilol is a nonselective beta-adrenergic receptor antagonist that also blocks alpha-1 adrenergic receptors. Metoprolol is a selective beta-1 adrenergic receptor antagonist. Clonidine is a centrally acting alpha-2 adrenergic receptor agonist. Eplerenone is a selective mineralocorticoid receptor antagonist.

Correct Answer

D — Selective mineralocorticoid receptor antagonists

Rationale

Eplerenone is a selective mineralocorticoid receptor antagonist. Doxazosin is an alpha-1 adrenergic receptor antagonist. Bisoprolol is a beta-adrenergic receptor antagonist. Amiloride is a potassium-sparing diuretic that acts independently of aldosterone receptor blockade.

Correct Answer

A — Potassium-sparing diuretic

Rationale

Amiloride is a potassium-sparing diuretic that blocks epithelial sodium channels directly, independent of aldosterone receptor binding. Spironolactone is a mineralocorticoid receptor antagonist. Hydrochlorothiazide is a thiazide diuretic. Furosemide is a loop diuretic.

Correct Answer

C — Dose-response curves for adverse effects are steeper than for efficacy — combining two drugs at half-standard doses achieves blood pressure reduction equivalent to full-dose monotherapy while exposing the patient to fewer adverse effects

Rationale

For most antihypertensive drug classes, the dose-response relationship for blood pressure reduction is relatively flat above moderate doses — doubling the dose produces much less than double the antihypertensive effect. However, adverse effects increase steeply with dose: electrolyte disturbances with diuretics, ankle edema with calcium channel blockers, and cough or hyperkalemia with renin-angiotensin-aldosterone system inhibitors all become substantially more frequent at higher doses. Combining two drugs at half-standard doses therefore achieves similar or greater blood pressure reduction compared with full-dose monotherapy, while the adverse effect burden of each individual drug remains in the lower, better-tolerated portion of its dose-response curve. Additionally, single-pill combinations of two drugs improve patient adherence by 20 to 30 percent compared with separate pills, addressing non-adherence — the most common cause of treatment failure in clinical practice.

Correct Answer

B — Volume depletion from the diuretic activates the renin-angiotensin-aldosterone system, increasing its contribution to blood pressure maintenance and amplifying the effect of renin-angiotensin-aldosterone system inhibition; the renin-angiotensin-aldosterone system inhibitor simultaneously blunts the diuretic-induced hypokalemia and hormonal activation

Rationale

Thiazide diuretics produce natriuresis and volume depletion, which reflexively activates the renin-angiotensin-aldosterone system — more renin is released, more angiotensin II is generated, and more aldosterone is secreted. This counter-regulatory response limits how much the diuretic alone can lower blood pressure, because angiotensin II-driven vasoconstriction and aldosterone-mediated sodium retention partially offset the volume-depleting effect. A renin-angiotensin-aldosterone system inhibitor directly blocks this counter-regulatory activation, preventing the angiotensin II rebound and aldosterone rise. This means the diuretic can lower blood pressure more effectively because the hormonal escape mechanism is blocked. In return, the renin-angiotensin-aldosterone system inhibitor reduces the diuretic-induced potassium wasting (since aldosterone is the driver of potassium excretion in the collecting duct). Each drug enhances the other's efficacy while mitigating the other's main adverse effect — a true pharmacological synergy.

Correct Answer

D — Calcium channel blockers and thiazide diuretics are the most effective initial monotherapy because they address volume and vascular tone directly without depending on renin-angiotensin-aldosterone system suppression; renin-angiotensin-aldosterone system inhibitors achieve equivalent efficacy when combined with a diuretic or calcium channel blocker

Rationale

Low-renin hypertension is driven by sodium retention and volume expansion rather than by renin-angiotensin-aldosterone system overactivation. Drug classes that target volume (thiazide diuretics) or reduce total peripheral resistance through renin-angiotensin-aldosterone system-independent mechanisms (dihydropyridine calcium channel blockers) are therefore more effective as initial monotherapy in this setting. Renin-angiotensin-aldosterone system inhibitors — angiotensin converting enzyme inhibitors and angiotensin receptor blockers — produce less blood pressure reduction as monotherapy in low-renin states because there is less active renin-angiotensin-aldosterone system to inhibit. However, when combined with a diuretic or calcium channel blocker, they achieve comparable efficacy to other regimens and are appropriate when compelling indications such as chronic kidney disease, heart failure with reduced ejection fraction, or diabetes are present. An additional consideration for Black patients is the three to four times higher risk of angiotensin converting enzyme inhibitor-associated angioedema compared with White patients, making angiotensin receptor blockers the preferred renin-angiotensin-aldosterone system inhibitor when that class is indicated.

Correct Answer

A — Hypertensive urgency — no acute target organ damage is present; oral antihypertensive therapy with blood pressure reduction over 24 to 48 hours and close follow-up is appropriate; intravenous therapy and hospitalization are not required

Rationale

The critical distinction between hypertensive urgency and hypertensive emergency is not the blood pressure number — it is the presence or absence of acute target organ damage. A hypertensive emergency requires evidence of active organ injury: encephalopathy, acute stroke, aortic dissection, acute coronary syndrome, acute pulmonary edema, severe acute kidney injury, or eclampsia. This patient is asymptomatic with a normal neurological examination, so despite a blood pressure of 196/118, he has hypertensive urgency, not emergency. The appropriate management is oral antihypertensive therapy — options include oral clonidine 0.2 mg, captopril, or resuming or adjusting the patient's existing regimen — with blood pressure reduction over 24 to 48 hours and close outpatient follow-up within 24 to 72 hours. Rapid blood pressure reduction in urgency is inappropriate and potentially harmful: patients with chronic hypertension have upward-shifted cerebral autoregulation, and rapid lowering can cause ischemia in organs accustomed to elevated pressure.

Correct Answer

C — Reduce mean arterial pressure by no more than 25 percent in the first hour — patients with chronic hypertension have upward-shifted autoregulation, so rapid reduction to normal levels can cause ischemia in organs accustomed to elevated pressure

Rationale

In patients with long-standing hypertension, cerebral and renal autoregulation is reset to maintain perfusion at higher-than-normal arterial pressures. The lower limit of the autoregulatory range shifts upward, meaning that blood pressure levels that would be normal in a healthy person may represent a relative hypotension in a chronically hypertensive patient. Reducing blood pressure rapidly to normal levels can therefore cause ischemia in the brain, heart, or kidneys before autoregulation can re-adapt. The guideline-recommended approach is to reduce mean arterial pressure by no more than 25 percent in the first hour, then target 160/100 to 110 millimeters of mercury over the subsequent two to six hours, with gradual normalization toward goal over 24 to 48 hours. Exceptions to this stepwise approach include acute aortic dissection (where the target is systolic below 120 millimeters of mercury as rapidly as safely possible) and severe preeclampsia or eclampsia.

Correct Answer

B — Do not lower the blood pressure unless it reaches 220/120 millimeters of mercury — elevated blood pressure in acute ischemic stroke is often a physiological response maintaining perfusion in the ischemic penumbra surrounding the infarct core

Rationale

In acute ischemic stroke, the brain tissue surrounding the core infarct (the penumbra — the region of brain that is functionally impaired but still viable) depends on collateral blood flow to survive. Elevated blood pressure in this setting is often a compensatory response that helps drive blood through partially occluded or collateral vessels into the penumbra. Lowering blood pressure prematurely can reduce perfusion pressure in these vulnerable territories and extend the infarct into salvageable tissue. Current guidelines therefore recommend withholding antihypertensive treatment in acute ischemic stroke unless blood pressure reaches 220/120 millimeters of mercury or higher. The exception is when thrombolysis (clot-dissolving therapy) or thrombectomy (mechanical clot removal) is planned — in that case, blood pressure must be below 185/110 millimeters of mercury before the procedure to reduce the risk of hemorrhagic transformation. This represents a counterintuitive but evidence-based exception to the general rule that elevated blood pressure in emergencies requires treatment.

Correct Answer

D — Low renin indicates that volume expansion and aldosterone excess — rather than sympathetic overactivation or vasoconstriction — is the dominant blood pressure-maintaining mechanism, making aldosterone blockade with spironolactone the most targeted intervention

Rationale

Plasma renin activity reflects the degree to which the renin-angiotensin-aldosterone system is activated to maintain blood pressure. When renin is suppressed, it indicates that blood pressure is being maintained through volume excess rather than renin-angiotensin-aldosterone system activation — the system is shut down by the negative feedback from expanded blood volume and sodium retention. In this state, aldosterone may be autonomous or relatively autonomous, continuing to drive sodium reabsorption and potassium wasting despite low renin. Spironolactone, by blocking mineralocorticoid receptors, directly attacks this volume-and-aldosterone mechanism. Patients with high renin resistant hypertension, where the renin-angiotensin-aldosterone system is already being suppressed by existing renin-angiotensin-aldosterone system inhibitor therapy or where sympathetic activation is dominant, respond less robustly. This biomarker relationship provides a physiologically coherent explanation for why spironolactone outperformed a beta-blocker and an alpha-blocker as fourth-line therapy in the crossover trial.

Correct Answer

A — Single-pill combinations improve medication adherence by 20 to 30 percent compared with separate pills by reducing pill burden — non-adherence is the most common cause of apparent treatment failure in hypertension

Rationale

Studies consistently show that patients who take fewer pills daily have better adherence to antihypertensive therapy. Reducing two separate pills to one combined tablet decreases the frequency and complexity of medication-taking and is associated with a 20 to 30 percent improvement in long-term adherence. Non-adherence — not drug resistance or inadequate dosing — is the most common reason blood pressure remains uncontrolled despite an apparently appropriate regimen. Before labeling a patient as having resistant hypertension, non-adherence must be explicitly assessed, including through urine drug level testing if clinical concern is high. Single-pill combinations do not create pharmacokinetic changes or alter individual drug bioavailability. The benefit is entirely practical: fewer pills taken more reliably translates into more consistent blood pressure control and better cardiovascular outcomes.

Correct Answer

C — Replace hydrochlorothiazide with a loop diuretic — thiazide efficacy is markedly reduced below an estimated glomerular filtration rate of approximately 30 mL per minute because insufficient sodium reaches the distal convoluted tubule for the drug to block

Rationale

Thiazide diuretics block the sodium-chloride cotransporter in the distal convoluted tubule, a nephron segment that normally handles only 5 to 10 percent of filtered sodium. As glomerular filtration falls, the total sodium filtered decreases and more of what is filtered is reabsorbed proximally — leaving little sodium to reach the distal convoluted tubule. Below an estimated glomerular filtration rate of approximately 30 mL per minute, thiazide diuretics have markedly reduced natriuretic efficacy regardless of dose. This explains the persistent volume overload and inadequate blood pressure control in this patient. Loop diuretics act at the thick ascending limb of the loop of Henle, which handles approximately 25 percent of filtered sodium and remains effective even at markedly reduced glomerular filtration rates. Switching to furosemide or torsemide directly addresses both the volume overload and the blood pressure goal. Spironolactone adds fourth-line resistance management but does not replace the need for adequate primary diuresis.

Correct Answer

B — White coat hypertension — office readings are elevated by the clinical environment while out-of-office readings are normal; no additional antihypertensive therapy is indicated and adding a fourth drug risks over-treatment

Rationale

White coat hypertension is defined as elevated blood pressure in the office setting with normal readings on ambulatory or home monitoring. In this patient, ambulatory daytime blood pressure of 124/78 is well within the normal range (target below 130/80), confirming that her blood pressure is adequately controlled outside the office environment. The elevated office readings reflect an autonomic response to the clinical setting — heightened alertness, anxiety, or the presence of a healthcare provider — that transiently elevates blood pressure without representing true sustained hypertension. This is pseudo-resistance, not true resistant hypertension. Adding a fourth antihypertensive agent in this scenario would be inappropriate and potentially dangerous, risking hypotension, falls, and electrolyte disturbances. The appropriate management is to reassure the patient, continue the current regimen, and monitor with periodic ambulatory or home blood pressure monitoring to confirm ongoing control.

Correct Answer

A — Preferred agents: intravenous labetalol, oral nifedipine (immediate-release), or intravenous hydralazine; agents to avoid: angiotensin converting enzyme inhibitors and angiotensin receptor blockers (fetal renal harm), and sodium nitroprusside (fetal cyanide toxicity)

Rationale

Severe preeclampsia requires prompt blood pressure reduction when systolic reaches 160 or diastolic reaches 110 millimeters of mercury, with treatment initiated within 30 to 60 minutes to prevent maternal stroke and other complications. The three preferred acute antihypertensive agents are intravenous labetalol (combined alpha-beta blockade, safe in pregnancy), immediate-release oral nifedipine (a dihydropyridine calcium channel blocker with rapid onset), and intravenous hydralazine (a direct arteriolar vasodilator with decades of use in obstetric emergencies). Angiotensin converting enzyme inhibitors and angiotensin receptor blockers are absolutely contraindicated throughout pregnancy because they disrupt fetal renin-angiotensin-aldosterone system-dependent renal development, causing renal dysgenesis, oligohydramnios (reduced amniotic fluid), and neonatal renal failure. Sodium nitroprusside is contraindicated in pregnancy because cyanide released during its metabolism can cross the placenta and cause fetal cyanide toxicity. Magnesium sulfate is used concurrently for seizure prophylaxis in preeclampsia but is not an antihypertensive agent.

Correct Answer

D — Amlodipine is the correct choice because it is a vascular-selective dihydropyridine with minimal cardiac depression; verapamil and diltiazem are contraindicated in heart failure with reduced ejection fraction because their negative inotropic effects further reduce myocardial contractility in an already-compromised ventricle

Rationale

The critical distinction in this scenario is between dihydropyridine and non-dihydropyridine calcium channel blockers. Amlodipine is a dihydropyridine with high vascular-to-cardiac selectivity — it lowers blood pressure by dilating arterioles with minimal direct effect on myocardial contractility, sinoatrial node automaticity, or atrioventricular conduction. Large outcome trials in heart failure have confirmed that amlodipine does not worsen outcomes and is safe to add for blood pressure control. Verapamil and diltiazem are non-dihydropyridines with substantial negative inotropic effects — they reduce myocardial contractility by blocking cardiac L-type calcium channels. In a patient with already-reduced ejection fraction of 32 percent, adding a negative inotrope can precipitate acute decompensation, worsening heart failure. Combining verapamil or diltiazem with carvedilol also creates additive suppression of sinoatrial and atrioventricular nodal conduction, risking severe bradycardia or complete heart block. Non-dihydropyridine calcium channel blockers are therefore contraindicated in heart failure with reduced ejection fraction.